Related Experiment Video
Updated: May 11, 2026

17:08
In vivo Clonal Tracking of Hematopoietic Stem and Progenitor Cells Marked by Five Fluorescent Proteins using Confocal and Multiphoton Microscopy
Published on: August 6, 2014
Biocompatible fluorescent nanoparticles for in vivo stem cell tracking.
Lidia Cova1, Paolo Bigini, Valentina Diana
1Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy.
Nanotechnology
|May 22, 2013
Summary
Researchers developed biocompatible fluorescent nanoparticles (fluoNPs) for tracking stem cells. These fluoNPs safely label and monitor human amniotic fluid cells in the brain, aiding neurodegenerative disease research.
Area of Science:
- Biomaterials Science
- Stem Cell Biology
- Neuroscience
Background:
- Stem cell therapy for neurodegenerative diseases requires reliable methods for tracking transplanted cells.
- Current cell tracking methods may have limitations in terms of safety and long-term monitoring.
- Understanding stem cell fate is crucial for optimizing therapeutic strategies.
Purpose of the Study:
- To synthesize and characterize novel fluorescent nanoparticles (fluoNPs) for safe and efficient stem cell labeling.
- To evaluate the impact of fluoNPs on the biological properties of human amniotic fluid cells (hAFCs).
- To demonstrate the utility of fluoNPs for longitudinal tracking of transplanted hAFCs in vivo.
Main Methods:
- Synthesis of methyl methacrylate (MMA)-based fluorescent nanoparticles (fluoNPs) via free-radical co-polymerization.
- Labeling of multipotent human amniotic fluid cells (hAFCs) with fluoNPs.
- Assessment of hAFC viability, proliferation, and metabolic activity post-labeling.
- Longitudinal tracking of labeled hAFCs in mouse brain ventricles using fluorescence imaging.
- Confirmation of tracking reliability using magnetic resonance imaging (MRI) with superparamagnetic iron oxide nanoparticles (SPIONs).
Main Results:
- Successfully synthesized biocompatible and fluorescent MMA-based nanoparticles (fluoNPs).
- fluoNPs efficiently labeled hAFCs without compromising cell viability, growth, or metabolic activity.
- Longitudinal biodistribution of transplanted hAFCs in mouse brains was successfully determined using fluorescence imaging.
- The developed method was validated by complementary MRI analyses.
Conclusions:
- Biocompatible fluoNPs provide an effective tool for labeling and tracking stem cells.
- This approach enables longitudinal monitoring of stem cell behavior in vivo.
- fluoNPs hold promise for advancing stem cell-based therapies for neurodegenerative diseases.

